Brought to you by:
First patient enrolled in DEFIANCE trial of the ClotTriever system in DVT
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the ClotTriever system versus anticoagulation only. The trial is…
SVS Foundation: Get ‘Gatsby’ Gala tickets today
Tickets—both individual and for tables—are selling faster than a Gin Rickey during Prohibition for the Society for Vascular Surgery (SVS) Foundation’s “Great Gatsby Gala,” to be held at the 2023 Vascular Annual Meeting (VAM). From Feb. 3 to 18, individual…
VESAP5: Now up to 25% off
With the expiration of the fifth edition of the Vascular Education and Self-Assessment Program (VESAP5) in July, the Society for Vascular Surgery (SVS) is offering a discount of up to 25% on the program for a limited time. The discount…
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons and better coverage of SVS priorities’
Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory University in Atlanta—offered observations on the National Institutes of Health’s (NIH) “modestly” aligned vascular surgical funding…
High-risk venous stasis ulceration patients show similar healing rates after multi-modal surgical therapy
A single-center evaluation of contemporary, multi-modal surgical therapy for venous stasis ulceration (C6 disease) suggests high-risk patients showed similar healing rates at one year, indicating a variety of intervention types should be pursued to achieve “optimal results.” Presented at the…
Has the risk in the value-based payment model been sold as another ‘shiny new object’?
Value-based payments (VBP), or “volume to value,” was the new buzz word over a decade ago, promising yet another chimera in ways to reimburse physicians and hospitals based upon “value,” instead of fee-for-service (FFS). VBP models link payment or compensation to…
Back to basics: All the things I love about vascular surgery
Recently, after completing a difficult open aortic operation with my attending, a bright M3 asked me, “Why vascular surgery?” The question didn’t catch me off guard, as I always have a ready answer, and we had just finished a pretty…
‘Unique’ vascular meeting set to update surgeons, prioritize audience debate
Prioritizing “entertaining and informative” sessions, the 29th Annual Pennsylvania Hospital Vascular Symposium and the 3rd Annual Pennsylvania Hospital/University of Pennsylvania Non-invasive Vascular Laboratory Symposium (April 21–22) in Philadelphia returns, providing the latest open surgical and endovascular management of vascular disease.…
Get FIT: Applications for VQI Fellowship in Training program open
The Fellowship in Training (FIT) from the Society for Vascular Surgery’s Vascular Quality Initiative (SVS VQI) introduces residents and fellows in vascular-focused programs to the SVS Patient Safety Organization (PSO). FIT debuted just a year ago, in January 2022, with 16…
The year in review: 2022 was an amazing 12 months for SVS
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023. Executive Director Kenneth M. Slaw, PhD, outlined a number of firsts for the Society, including: The year…